Compensation Agreements in the Health Care Equipment & Supplies Industry
618 Contracts & Agreements
- Abbott Laboratories (5 contracts)
- ABIOMED Inc (20)
- Acrivon Therapeutics, Inc. (1)
- Adams Respiratory Therapeutics, Inc. (2)
- AETHLON MEDICAL INC (5)
- Akari Therapeutics Plc (2)
- ALLOS THERAPEUTICS INC (1)
- Angiodynamics Inc (2)
- ANTARES PHARMA, INC. (1)
- Apollo Endosurgery, Inc. (3)
- ARATANA THERAPEUTICS, INC. (6)
- Arno Therapeutics, Inc (1)
- ARYx Therapeutics, Inc. (1)
- ATRION CORP (3)
- Baxter International Inc. (30)
- Becton Dickinson (20)
- Bionik Laboratories Corp. (4)
- Bioventus Inc. (2)
- Boston Scientific (2)
- Cardiovascular Systems Inc (14)
- CARGO Therapeutics, Inc. (1)
- Carmot Therapeutics Inc. (1)
- CERUS CORP (16)
- CHEMBIO DIAGNOSTICS, INC. (1)
- CHF Solutions, Inc. (4)
- Cirius Therapeutics, Inc. (1)
- Colfax CORP (8)
- CORNERSTONE THERAPEUTICS INC (5)
- Coronado Topco, Inc. (2)
- CryoLife, Inc. (18)
- Cue Health Inc. (1)
- D8 Holdings Corp. (2)
- Danaher Corp. (28)
- Dare Bioscience, Inc. (4)
- Dentsply Sirona (12)
- DEXCOM INC (1)
- Durata Therapeutics, Inc. (3)
- Eargo, Inc. (2)
- Edwards Lifesciences (2)
- electroCore, Inc. (5)
- Electromed, Inc. (1)
- Embecta Corp. (4)
- ENDRA Life Sciences Inc. (5)
- Envista Holdings Corp (3)
- FEMASYS INC (1)
- FIGS, Inc. (1)
- GI DYNAMICS, INC. (2)
- GLAUKOS Corp (5)
- Haemonetics (4)
- HealthCor Catalio Acquisition Corp. (2)
- HELIUS MEDICAL TECHNOLOGIES, INC. (2)
- Heska Corporation (7)
- Hill-Rom Holdings Inc. (4)
- Hologic (4)
- ICU Medical (33)
- IDEXX Laboratories (3)
- Inari Medical, Inc. (5)
- Inogen, Inc. (1)
- INSULET CORP (1)
- Insys Therapeutics, Inc. (1)
- INTARCIA THERAPEUTICS, INC (1)
- Integer Holdings Corporation (2)
- Integra Lifesciences Holdings (8)
- INTRICON CORP (3)
- Invacare Corporation (22)
- Invea Therapeutics, Inc (1)
- INVIVO THERAPEUTICS HOLDINGS CORP. (1)
- IRADIMED CORP (1)
- Juno Therapeutics, Inc. (2)
- KEWAUNEE SCIENTIFIC CORP (7)
- Kyverna Therapeutics, Inc. (1)
- LeMaitre Vascular, Inc. (2)
- LENSAR, Inc. (3)
- LivaNova (3)
- Longview Acquisition Corp. (4)
- Lucira Health, Inc. (1)
- MABVAX THERAPEUTICS HOLDINGS, INC. (1)
- Masimo (3)
- Meridian Bioscience, Inc. (3)
- Merit Medical Systems, Inc. (2)
- Mineralys Therapeutics, Inc. (1)
- MINERVA SURGICAL INC (1)
- MRI INTERVENTIONS, INC. (4)
- Neogen Corporation (1)
- Neon Therapeutics, Inc. (1)
- Neumora Therapeutics, Inc. (2)
- NeuroMetrix, Inc. (1)
- Neuronetics, Inc. (1)
- NEUROONE MEDICAL TECHNOLOGIES Corp (1)
- NEVRO CORP (5)
- NovoCure Ltd (6)
- NuVasive Inc (3)
- OBALON THERAPEUTICS INC (1)
- Ocera Therapeutics, Inc. (7)
- OraSure Technologies, Inc. (6)
- Orexigen Therapeutics, Inc. (2)
- Orthofix Medical Inc. (5)
- ORTHOPEDIATRICS CORP (4)
- Pandion Therapeutics Holdco LLC (1)
- Paragon 28, Inc. (1)
- Peloton Therapeutics, Inc. (1)
- PRECISION OPTICS CORPORATION, INC. (4)
- PRO DEX INC (3)
- PROCEPT BioRobotics Corp (2)
- Pulmonx Corp (3)
- Q Therapeutics, Inc. (1)
- QUIDEL CORP (3)
- ResMed (1)
- Restoration Robotics, Inc. (1)
- ReWalk Robotics Ltd. (4)
- RxSight, Inc. (1)
- Salona Global Medical Device Corp (1)
- Sandbridge Acquisition Corp (1)
- SeaSpine Holdings Corp (4)
- SECOND SIGHT MEDICAL PRODUCTS INC (1)
- Senseonics Holdings, Inc. (4)
- ShockWave Medical, Inc. (6)
- SI-BONE, Inc. (3)
- Sientra, Inc. (1)
- Sight Sciences, Inc. (1)
- SIRNA THERAPEUTICS INC (1)
- SmileDirectClub, Inc. (4)
- Sonendo, Inc. (1)
- STAAR SURGICAL CO (4)
- Stereotaxis, Inc. (16)
- STERIS Ltd (4)
- STERIS plc (3)
- Structure Therapeutics Inc. (2)
- Surmodics, Inc. (8)
- Synvista Therapeutics, Inc. (2)
- TACTILE SYSTEMS TECHNOLOGY INC (4)
- Talis Biomedical Corp (3)
- Talon Therapeutics, Inc. (3)
- TANDEM DIABETES CARE INC (1)
- TELA Bio, Inc. (5)
- Teleflex Inc (5)
- The Cooper Companies (1)
- Tobira Therapeutics, Inc. (5)
- TRANSENTERIX INC. (5)
- TREACE MEDICAL CONCEPTS, INC. (2)
- UTAH MEDICAL PRODUCTS INC (13)
- Varian Medical Systems (1)
- VIVEVE MEDICAL, INC. (3)
- Vividion Therapeutics, Inc. (1)
- West Pharmaceutical Services (6)
- Zimmer Biomet Holdings (10)
- ZimVie Inc. (1)
- Zosano Pharma Corp (1)
- ZYNEX INC (1)
- Summary of Officer and Director Compensation (UTAH MEDICAL PRODUCTS INC, Filed With SEC on March 26, 2024)
- TELA Bio, Inc. Amended and Restated Non-Employee Director Compensation Policy (TELA Bio, Inc., Filed With SEC on March 22, 2024)
- QuidelOrtho Employee Deferred Compensation Plan (Coronado Topco, Inc., Filed With SEC on February 29, 2024)
- QuidelOrtho Board Deferred Compensation Plan (Coronado Topco, Inc., Filed With SEC on February 29, 2024)
- Non-Employee Director Compensation Program (Inari Medical, Inc., Filed With SEC on February 29, 2024)
- Non-Employee Director Compensation Program (PROCEPT BioRobotics Corp, Filed With SEC on February 28, 2024)
- Outside Director Compensation Policy (RxSight, Inc., Filed With SEC on February 28, 2024)
- Non-employee director compensation (ICU Medical, Filed With SEC on February 27, 2024)
- Executive officer compensation (ICU Medical, Filed With SEC on February 27, 2024)
- Letter of the Company, dated October 24, 2023 to Nathaniel Sisitsky, General Counsel, regarding compensation (STAAR SURGICAL CO, Filed With SEC on February 27, 2024)
- Non-Employee Director Compensation Policy (TREACE MEDICAL CONCEPTS, INC., Filed With SEC on February 27, 2024)
- Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy (Pulmonx Corp, Filed With SEC on February 27, 2024)
- Summary of 2023 Compensation Arrangements with Non-Employee Directors (CryoLife, Inc., Filed With SEC on February 23, 2024)
- Non-Employee Director Compensation Program (NovoCure Ltd, Filed With SEC on February 22, 2024)
- Description of compensation arrangements for non-management directors (Danaher Corp., Filed With SEC on February 21, 2024)
- Amendment No. 1 to the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan (Embecta Corp., Filed With SEC on February 9, 2024)
- Baxter International Inc. Directors' Deferred Compensation Plan (amended and restated effective January 31, 2024) (as amended and restated effective January 31, 2024) (Baxter International Inc., Filed With SEC on February 8, 2024)
- Kyverna Therapeutics, Inc. Non-Employee Director Compensation Program (Kyverna Therapeutics, Inc., Filed With SEC on February 1, 2024)
- The Cooper Companies, Inc. Compensation Recovery Policy (The Cooper Companies, Filed With SEC on December 8, 2023)
- 2004 Employee and Director Equity-Based Compensation Plan, as amended and restated as of July 25, 2023 (Becton Dickinson, Filed With SEC on November 21, 2023)
- Carmot Therapeutics Inc. Non-Employee Director Compensation Policy (Carmot Therapeutics Inc., Filed With SEC on November 17, 2023)
- Owlet, Inc. Non-Employee Director Compensation Program (Sandbridge Acquisition Corp, Filed With SEC on November 14, 2023)
- Description of STERIS plc Non-Employee Director Compensation Program (STERIS Ltd, Filed With SEC on November 7, 2023)
- Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as amended August 25, 2023 (Zimmer Biomet Holdings, Filed With SEC on November 7, 2023)
- Non-Employee Director Compensation Program (CARGO Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Iradimed Corporation Incentive-Based Compensation Recovery Policy (IRADIMED CORP, Filed With SEC on November 6, 2023)
- Nevro Corp. Non-Employee Director Compensation Program, as amended (NEVRO CORP, Filed With SEC on November 1, 2023)
- Non-Employee Director Compensation Policy (Invea Therapeutics, Inc, Filed With SEC on October 20, 2023)
- Non-Employee Director Compensation Program (Neumora Therapeutics, Inc., Filed With SEC on September 11, 2023)
- Non-Employee Director Compensation Program (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
- Form of electroCore, Inc. Non-Employee Director Compensation Policy (electroCore, Inc., Filed With SEC on August 24, 2023)
- 2023 Non-Employee Directors' Compensation Policy (SI-BONE, Inc., Filed With SEC on August 8, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (ShockWave Medical, Inc., Filed With SEC on August 7, 2023)
- Amended Non-Employee Director Compensation Policy (Structure Therapeutics Inc., Filed With SEC on August 4, 2023)
- Pulmonx Corporation Amended and Restated Non-Employee Director Compensation Policy (Pulmonx Corp, Filed With SEC on August 4, 2023)
- Amendment No. 1 to the Hologic, Inc. Amended and Restated Deferred Compensation Program (Hologic, Filed With SEC on August 1, 2023)
- Integer Holdings Corporation Director Compensation Policy (most recently amended and restated May 24, 2023) (Integer Holdings Corporation, Filed With SEC on July 27, 2023)
- Nonemployee Director Compensation Policy, As Amended (HealthCor Catalio Acquisition Corp., Filed With SEC on June 12, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (D8 Holdings Corp., Filed With SEC on June 7, 2023)
- Form of Employee and Director PSU and RSU Awards under the 2022 Employee and Director Equity Based Compensation Plan and Conditions of Awards (November 26, 2022) (Embecta Corp., Filed With SEC on May 12, 2023)
